title: Second and third line chemotherapy in advanced breast cancer.
authors.affiliation: 1st Dept. of Medical Oncology, St. Savas Hosp., Athens, Greece.
authors.forename: A
authors.initials: A
authors.lastname: Alexopoulos
authors.forename: G
authors.initials: G
authors.lastname: Rigatos
authors.forename: E
authors.initials: E
authors.lastname: Stavrinidis
authors.forename: J
authors.initials: J
authors.lastname: Stavrakakis
authors.forename: C
authors.initials: C
authors.lastname: Scartsilas
authors.forename: A
authors.initials: A
authors.lastname: Papacharalambous
mesh_terms: D000505:Alopecia / Q000139:chemically induced; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D015251:Epirubicin; D016685:Mitomycin; D014750:Vincristine; D014747:Vinblastine